Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Legato Merger (LEGOU)
Foxwayne Enterprises Acquisition (FOXWU)
Gores Metropoulos II (GMIIU)
Tzp Strategies Acquisition (TZPSU)
Queen's Gambit Growth Capital (GMBTU)
Upcoming IPO
Roblox Corporation (RBLX)
Dream Finders Homes, Inc. (DFH)
Myt Netherlands (MYTE)
Primavera Capital Acquisition (PV.U)
Growth Capital Acquisition (GCACU)
Virtuoso Acquisition (VOSOU)
Patria Investments Limited (PAX)
Rlx Technology, Inc. (RLX)
European Sustainable Growth Acquisition (EUSGU)
Zim Integrated Shipping Services (ZIM)
Agrify (AGFY)
Shoals Technology Group, Inc. (SHLS)
Qualtrics International Inc. (XM)
Vinci Partners Investments Ltd. (VINP)
Ortho Clinical Diagnostics Holdings Plc (OCDX)
Priced IPO
Kuke Music Holding Limited (KUKE)
Playtika Holding Corp. (PLTK)
Driven Brands Holdings Inc. (DRVN)
Petco Health And Wellness Company, Inc. (WOOF)
Poshmark, Inc (POSH)
Affirm Holdings, Inc. (AFRM)
Motorsport Gaming US Llc (MSGM)
Qilian International Holding Group (QLI)
Cullinan Oncology, Llc (CGEM)
Gracell Biotechnologies Inc. (GRCL)
Medirom Healthcare Technologies (MRM)
Glucose Biosensor Systems Greater China (GBSG)
GBS (GBS)
908 Devices Inc. (MASS)
Virios Therapeutics (VIRI)
Midwest Holding (MDWT)
Scopus BioPharma (SCPS)
Upstart Holdings, Inc. (UPST)
BioAtla, Inc.. (BCAB)
Contextlogic Inc. (WISH)
More companies

Maravai LifeSciences Holdings, Inc. (MRVI)

Sector - Healthcare

Price chart

Company News

IPO Profile

About company

They are a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. Their more than 5,000 customers as of September 30, 2020 include the top 20 global biopharmaceutical companies ranked by research and development expenditures according to industry consultants, and many other emerging biopharmaceutical and life sciences research companies, as well as leading academic research institutes and in vitro diagnostics companies. Their products address the key phases of biopharmaceutical development and include complex nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. Their businesses principally serve high growth market segments in biopharmaceutical development and manufacturing. They estimate that the market segments they serve are growing at a weighted average blended rate of 20% per annum. In particular, the field of cell and gene therapy has emerged as one of the fastest growing treatment modalities to address a host of human conditions.
Industry
Pharmaceuticals
CEO CFO
Carl Hull Kevin Herde
Employees Founded
390 2014

Contacts

Address: 10770 Wateridge Circle Suite 200 San Diego, California 92121

Telephone: (858) 546-0004

Web page: http://www.maravai.com

IPO information

Expected Date 11/20/2020
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Financial Data (last reporting year)

Market Cap (MM) $2075.19
Revenues (MM) $221.7
Net Income (Loss) (MM) $59.4

Voting

What do you think will happen with the MRVI share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
Shares Initial (MM) 50
Shares Revised (MM) 60
Expected offer amount (MM) $1275
Realized offer amount(MM) $1620
Underwriters
Morgan Stanley/ Jefferies/ Goldman Sachs/ BofA Securities/ Credit Suisse/ UBS Investment Bank/ Baird/ William Blair/ Stifel/ KeyBanc Capital
CO-Managers
Academy Securities/ Loop Capital/ Penserra Securities/ Tigress Financial Partners

Sector: Healthcare

Tweets about $MRVI

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats